These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36972361)

  • 1. Revisiting Androgen Receptor Signaling in Breast Cancer.
    Dai C; Ellisen LW
    Oncologist; 2023 May; 28(5):383-391. PubMed ID: 36972361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling.
    Narayanan R; Ahn S; Cheney MD; Yepuru M; Miller DD; Steiner MS; Dalton JT
    PLoS One; 2014; 9(7):e103202. PubMed ID: 25072326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers.
    Ponnusamy S; Asemota S; Schwartzberg LS; Guestini F; McNamara KM; Pierobon M; Font-Tello A; Qiu X; Xie Y; Rao PK; Thiyagarajan T; Grimes B; Johnson DL; Fleming MD; Pritchard FE; Berry MP; Oswaks R; Fine RE; Brown M; Sasano H; Petricoin EF; Long HW; Narayanan R
    iScience; 2019 Nov; 21():341-358. PubMed ID: 31698248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor-Positive Breast Cancer.
    Wei L; Gao H; Yu J; Zhang H; Nguyen TTL; Gu Y; Passow MR; Carter JM; Qin B; Boughey JC; Goetz MP; Weinshilboum RM; Ingle JN; Wang L
    Cancer Res; 2023 Feb; 83(3):456-470. PubMed ID: 36469363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
    Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C
    Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor signaling pathways as a target for breast cancer treatment.
    Pietri E; Conteduca V; Andreis D; Massa I; Melegari E; Sarti S; Cecconetto L; Schirone A; Bravaccini S; Serra P; Fedeli A; Maltoni R; Amadori D; De Giorgi U; Rocca A
    Endocr Relat Cancer; 2016 Oct; 23(10):R485-98. PubMed ID: 27528625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
    Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
    J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the androgen receptor in prostate and breast cancer: several new agents in development.
    Proverbs-Singh T; Feldman JL; Morris MJ; Autio KA; Traina TA
    Endocr Relat Cancer; 2015 Jun; 22(3):R87-R106. PubMed ID: 25722318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of androgen receptor splice variants in clinical breast cancers.
    Hickey TE; Irvine CM; Dvinge H; Tarulli GA; Hanson AR; Ryan NK; Pickering MA; Birrell SN; Hu DG; Mackenzie PI; Russell R; Caldas C; Raj GV; Dehm SM; Plymate SR; Bradley RK; Tilley WD; Selth LA
    Oncotarget; 2015 Dec; 6(42):44728-44. PubMed ID: 26554309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer.
    Hickey TE; Dwyer AR; Tilley WD
    Br J Cancer; 2021 Dec; 125(12):1599-1601. PubMed ID: 34294894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research resource: interplay between the genomic and transcriptional networks of androgen receptor and estrogen receptor α in luminal breast cancer cells.
    Need EF; Selth LA; Harris TJ; Birrell SN; Tilley WD; Buchanan G
    Mol Endocrinol; 2012 Nov; 26(11):1941-52. PubMed ID: 23023562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology.
    Bleach R; McIlroy M
    Front Endocrinol (Lausanne); 2018; 9():594. PubMed ID: 30416486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bringing androgens up a NOTCH in breast cancer.
    Tarulli GA; Butler LM; Tilley WD; Hickey TE
    Endocr Relat Cancer; 2014 Aug; 21(4):T183-202. PubMed ID: 25001242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Androgen Receptor Modulator RAD140 Inhibits the Growth of Androgen/Estrogen Receptor-Positive Breast Cancer Models with a Distinct Mechanism of Action.
    Yu Z; He S; Wang D; Patel HK; Miller CP; Brown JL; Hattersley G; Saeh JC
    Clin Cancer Res; 2017 Dec; 23(24):7608-7620. PubMed ID: 28974548
    [No Abstract]   [Full Text] [Related]  

  • 15. Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.
    Elebro K; Bendahl PO; Jernström H; Borgquist S
    Breast Cancer Res Treat; 2017 Oct; 165(3):645-657. PubMed ID: 28643022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay of endocrine therapy, steroid pathways and therapeutic resistance: Importance of androgen in breast carcinoma.
    Takagi K; Miki Y; Ishida T; Sasano H; Suzuki T
    Mol Cell Endocrinol; 2018 May; 466():31-37. PubMed ID: 28918115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective Androgen Receptor Modulator in a Patient With Hormone-Positive Metastatic Breast Cancer.
    Vontela N; Koduri V; Schwartzberg LS; Vidal GA
    J Natl Compr Canc Netw; 2017 Mar; 15(3):284-287. PubMed ID: 28275030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-biomarkers associated with sex hormone receptors and recent therapeutic advancements: a comprehensive review.
    Anbarasu S; Anbarasu A
    Med Oncol; 2023 May; 40(6):171. PubMed ID: 37162589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
    Cochrane DR; Bernales S; Jacobsen BM; Cittelly DM; Howe EN; D'Amato NC; Spoelstra NS; Edgerton SM; Jean A; Guerrero J; Gómez F; Medicherla S; Alfaro IE; McCullagh E; Jedlicka P; Torkko KC; Thor AD; Elias AD; Protter AA; Richer JK
    Breast Cancer Res; 2014 Jan; 16(1):R7. PubMed ID: 24451109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
    García X; Elía A; Galizzi L; May M; Spengler E; Martínez Vázquez P; Burruchaga J; Gass H; Lanari C; Lamb CA
    Breast Cancer Res Treat; 2020 Feb; 180(1):257-263. PubMed ID: 31950383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.